BridgeBio to Participate in December Investor Conferences
Provided By GlobeNewswire
Last update: Nov 25, 2025
PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences:
Read more at globenewswire.com
